Cargando…
Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297040/ https://www.ncbi.nlm.nih.gov/pubmed/22473412 http://dx.doi.org/10.6061/clinics/2012(03)14 |
_version_ | 1782225819941208064 |
---|---|
author | Batista, José Gomes Soares, José Maria Maganhin, Carla Cristina Simões, Ricardo Santos Tomaz, Geraldez Baracat, Edmund Chada |
author_facet | Batista, José Gomes Soares, José Maria Maganhin, Carla Cristina Simões, Ricardo Santos Tomaz, Geraldez Baracat, Edmund Chada |
author_sort | Batista, José Gomes |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3297040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo |
record_format | MEDLINE/PubMed |
spelling | pubmed-32970402012-03-08 Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study Batista, José Gomes Soares, José Maria Maganhin, Carla Cristina Simões, Ricardo Santos Tomaz, Geraldez Baracat, Edmund Chada Clinics (Sao Paulo) Rapid Communication Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012-03 /pmc/articles/PMC3297040/ /pubmed/22473412 http://dx.doi.org/10.6061/clinics/2012(03)14 Text en Copyright © 2012 Hospital das Clínicas da FMUSP http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Rapid Communication Batista, José Gomes Soares, José Maria Maganhin, Carla Cristina Simões, Ricardo Santos Tomaz, Geraldez Baracat, Edmund Chada Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study |
title | Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study |
title_full | Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study |
title_fullStr | Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study |
title_full_unstemmed | Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study |
title_short | Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study |
title_sort | assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study |
topic | Rapid Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297040/ https://www.ncbi.nlm.nih.gov/pubmed/22473412 http://dx.doi.org/10.6061/clinics/2012(03)14 |
work_keys_str_mv | AT batistajosegomes assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy AT soaresjosemaria assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy AT maganhincarlacristina assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy AT simoesricardosantos assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy AT tomazgeraldez assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy AT baracatedmundchada assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy |